ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ)
$19.94 -0.96 (-4.5933%)
Analysed ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) News Sources
Ascentage Pharma Builds Momentum With 2 'Potential Blockbuster' Drugs, Oppenheimer Says
27-03-2026
yahoo.com
Global Insights Into 3 Growth Stocks With High Insider Ownership
17-04-2026
yahoo.com
Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting
20-04-2026
yahoo.com
Global Growth Companies With High Insider Ownership
20-04-2026
yahoo.com
Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ASCO 2026
22-04-2026
yahoo.com
Global Growth Companies With High Insider Ownership In April 2026
22-04-2026
yahoo.com
Ascentage Pharma to Participate in Three Upcoming Investor Conferences
12-05-2026
yahoo.com
Ascentage Pharma to Present 17 Clinical Advances at 2026 European Hematology Association Congress
13-05-2026
yahoo.com
Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026
22-05-2026
yahoo.com
Global Growth Companies Insiders Favor With Up To 40% Earnings Growth
25-05-2026
yahoo.com
What is the current price of ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ)?
The current price of ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) is $19.94.
ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) absolute price change since previous trading day?
The absolute price change of ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) since the previous trading day is $-0.96.
ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) percentage price change since previous trading day?
The percentage price change of ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) since the previous trading day is -4.5933%.
What is the most recent average sentiment score for ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ)?
The most recent average sentiment score for ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ)?
The most recent sentiment for ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) is .
SEC-8K** Filing Available For ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.